OrthoPediatrics' (KIDS) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS - Free Report) in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has a $42.00 target price on the stock.

Separately, Truist Financial decreased their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating on the stock in a research report on Wednesday, December 18th.

OrthoPediatrics Stock Performance

NASDAQ:KIDS traded down $1.45 during mid-day trading on Tuesday, hitting $23.55. 375,622 shares of the company traded hands, compared to its average volume of 305,862. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. OrthoPediatrics has a one year low of $21.02 and a one year high of $35.99. The firm has a market cap of $570.29 million, a price-to-earnings ratio of -19.15 and a beta of 1.14. The stock's fifty day moving average price is $24.20 and its 200-day moving average price is $27.41.

Institutional Investors Weigh In On OrthoPediatrics

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KIDS. Quarry LP purchased a new position in shares of OrthoPediatrics in the third quarter worth about $25,000. International Assets Investment Management LLC raised its holdings in shares of OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock worth $27,000 after purchasing an additional 966 shares during the last quarter. Quest Partners LLC acquired a new position in shares of OrthoPediatrics in the 2nd quarter valued at about $34,000. BNP Paribas Financial Markets boosted its stake in shares of OrthoPediatrics by 125.1% in the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock worth $94,000 after buying an additional 1,929 shares during the last quarter. Finally, Quantbot Technologies LP grew its holdings in OrthoPediatrics by 42.2% during the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company's stock worth $157,000 after acquiring an additional 1,712 shares during the period. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.